Weihai Baihe Biology Technological Co (SHSE:603102) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Weihai Baihe Biology Technological Co Debt-to-Equity?

Weihai Baihe Biology Technological Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1.8 Mil. Weihai Baihe Biology Technological Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Weihai Baihe Biology Technological Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,548.7 Mil. Weihai Baihe Biology Technological Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Weihai Baihe Biology Technological Co's Debt-to-Equity or its related term are showing as below:

During the past 8 years, the highest Debt-to-Equity Ratio of Weihai Baihe Biology Technological Co was 0.01. The lowest was 0.00. And the median was 0.00.

SHSE:603102's Debt-to-Equity is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 0.41
* Ranked among companies with meaningful Debt-to-Equity only.

Weihai Baihe Biology Technological Co Debt-to-Equity Historical Data

The historical data trend for Weihai Baihe Biology Technological Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weihai Baihe Biology Technological Co Debt-to-Equity Chart

Weihai Baihe Biology Technological Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

Weihai Baihe Biology Technological Co Quarterly Data
	Dec16	Dec17	Dec18	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Weihai Baihe Biology Technological Co's Debt-to-Equity

For the Packaged Foods subindustry, Weihai Baihe Biology Technological Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Weihai Baihe Biology Technological Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Weihai Baihe Biology Technological Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Weihai Baihe Biology Technological Co's Debt-to-Equity falls into.

Weihai Baihe Biology Technological Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Weihai Baihe Biology Technological Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.947	+	0)	/	1514.464
	=	0.00

Weihai Baihe Biology Technological Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.786	+	0)	/	1548.708
	=	0.00

Weihai Baihe Biology Technological Co (SHSE:603102) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Weihai Baihe Biology Technological Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Weihai Baihe Biology Technological Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Weihai Baihe Biology Technological Co (SHSE:603102) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Weihai Baihe Biology Technological Co Ltd (SHSE:603102) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

No. 552, Chengda Road, Swan Lake Economic and Technological Development Zone, Rongcheng City, Shandong Province, Weihai, CHN, 264321

Website

http://www.baiheshengwu.com

Weihai Baihe Biology Technological Co Ltd is engaged in the research and development, production and sales of nutritional health food.

Weihai Baihe Biology Technological Co (SHSE:603102) Headlines

No Headlines